Chemotherapy of metastatic urothelial carcinoma. cis-Diamminedichloroplatinum combination chemotherapy for patients with decreased renal function
Cis-diamminedichloroplatinum (CDDP) combination chemotherapy has induced a high response rate in the treatment of metastatic urothelial carcinoma at our clinic. However, due to the risks of renal failure, renal function manifested by creatinine clearance (Ccr) of more than 50 ml/min is suggested to...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 30(1984), 1 vom: 15. Jan., Seite 21-8 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
1984
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | English Abstract Journal Article Doxorubicin 80168379AG Creatinine AYI8EX34EU Cisplatin Q20Q21Q62J Fluorouracil U3P01618RT |